Biopharma Advised to Beat the Clock on Patent Reform
If biopharma companies heed the advice of their patent attorneys, there will be a mad dash to the Patent and Trademark Office (PTO) over the next few weeks as firms rush to file new patents before the reforms of the America Invents Act (AIA) take effect March 16.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter